CRISPR is a new gene-editing tool that has significant promise but also requires regulation. It allows for precise editing of DNA by using guide RNA and an enzyme called Cas9. This advance enables basic scientists to create transgenic animal models, agricultural scientists to develop disease-resistant crops, and medical scientists to potentially cure and prevent genetic diseases. However, it also raises concerns about potential misuse by the military, wealthy individuals, or rogue scientists. As a result, CRISPR will be one of the biggest scientific issues of the next decade, and responsible innovation organizations should determine their stance, talk to researchers, work with governing bodies like NAS, and help convey both benefits and needed oversight of this technology.